SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001711279-22-000024
Filing Date
2022-05-23
Accepted
2022-05-23 16:20:01
Documents
12
Period of Report
2022-05-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K krys-20220523.htm   iXBRL 8-K 52868
  Complete submission text file 0001711279-22-000024.txt   180828

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT krys-20220523.xsd EX-101.SCH 1914
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT krys-20220523_lab.xml EX-101.LAB 22164
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT krys-20220523_pre.xml EX-101.PRE 11598
6 EXTRACTED XBRL INSTANCE DOCUMENT krys-20220523_htm.xml XML 10347
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Filer) CIK: 0001711279 (see all company filings)

IRS No.: 821080209 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38210 | Film No.: 22951840
SIC: 2836 Biological Products, (No Diagnostic Substances)